Response Genetics Revenue and Competitors
Estimated Revenue & Valuation
- Response Genetics's estimated annual revenue is currently $3.3M per year.
- Response Genetics's estimated revenue per employee is $155,000
Employee Data
- Response Genetics has 21 Employees.
- Response Genetics grew their employee count by -12% last year.
Response Genetics's People
Name | Title | Email/Phone |
---|
Response Genetics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Response Genetics?
Response Genetics, Inc. (the "Company") is a CLIA-certified clinical laboratory focused on the development and sale of molecular diagnostic testing services for cancer. The Company's technologies enable extraction and analysis of genetic information derived from tumor cells stored as formalin-fixed and paraffin-embedded specimens. The Company's principal customers include oncologists and pathologists.
keywords:N/AN/A
Total Funding
21
Number of Employees
$3.3M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Response Genetics News
Epigenetics has this double function: They're inheritance systems, but they're also response systems. You respond to the environment not by...
The link appears to be rooted in genetics. ... It might also affect a person's response to anesthesia, which is given before procedures to...
Genetic variation in the cytochrome P4502C19 gene has been previously found associated with high ADP-induced platelet aggregation in clopidogrel...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.7M | 21 | -9% | N/A |
#2 | $2.1M | 21 | 5% | N/A |
#3 | $2.1M | 21 | 5% | N/A |
#4 | $2.1M | 21 | -30% | N/A |
#5 | N/A | 21 | -50% | N/A |